마이크로니들 약물전달 시스템 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2033년)

Persistence Market Research has recently published a detailed report on the global Microneedle Drug Delivery Systems market. This report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing comprehensive insights into the market structure.

Key Insights:

• Microneedle Drug Delivery Systems Market Size (2024E): USD 6.7 Bn
• Projected Market Value (2033F): USD 10.8 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 5.4%

Microneedle Drug Delivery Systems Market - Report Scope:

The Microneedle Drug Delivery Systems market encompasses a range of technologies designed to deliver drugs painlessly and effectively through the skin using microneedles. This market includes various types of microneedle devices such as solid microneedles, hollow microneedles, and dissolving microneedles, which are crucial for transdermal drug delivery and vaccination. The market serves different segments, including pharmaceuticals, cosmetics, and diagnostics, distributed through retail, hospitals, and clinics. Growth is driven by increasing consumer interest in minimally invasive drug delivery methods, rising awareness about pain-free administration, and the growing trend of self-administration of drugs.

Market Growth Drivers:

Several key factors drive the global Microneedle Drug Delivery Systems market. The rising prevalence of chronic diseases and the need for effective drug delivery systems boost demand for microneedle technologies. Technological advancements in microneedle design and materials enhance performance and reliability, fueling market expansion. Additionally, the growing trend of self-medication and home healthcare drives the demand for user-friendly and non-invasive drug delivery systems. Increased disposable income and a focus on premium healthcare solutions also contribute to market growth.

Market Restraints:

Despite promising growth prospects, the Microneedle Drug Delivery Systems market faces challenges related to the high cost of advanced microneedle systems and fluctuating raw material prices. The market is also impacted by regulatory hurdles and the need for continuous innovation to meet evolving consumer preferences. Furthermore, the market is influenced by the presence of numerous local and unorganized players offering lower-cost alternatives, which can limit market share for established brands. Effective supply chain management, competitive pricing, and ongoing investment in research and development are necessary to address these issues and maintain a competitive edge.

Market Opportunities:

The market presents significant opportunities driven by the rising trend of personalized medicine and targeted drug delivery. The development of high-efficiency and eco-friendly microneedle systems caters to the growing demand for sustainable and advanced healthcare technologies. The expansion of e-commerce platforms provides new channels for market growth, allowing companies to reach a broader audience. Increasing urbanization and the rising number of health-conscious consumers drive the demand for high-quality microneedle systems. Strategic partnerships, investments in new technologies, and the introduction of innovative drug delivery solutions are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Microneedle Drug Delivery Systems market globally?
• Which microneedle types and application areas are leading the adoption of microneedle drug delivery systems?
• How are technological advancements influencing the competitive landscape of the Microneedle Drug Delivery Systems market?
• Who are the key players in the Microneedle Drug Delivery Systems market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Microneedle Drug Delivery Systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global Microneedle Drug Delivery Systems market, including 3M, Becton Dickinson and Company, and Zosano Pharma Corporation, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced microneedle technologies, such as dissolvable microneedles and integrated microneedle patches. Collaborations with pharmaceutical companies, research institutions, and online platforms facilitate market access and promote new product adoption. Emphasis on sustainable manufacturing processes, high-performance materials, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Microneedle Drug Delivery Systems landscape.

Key Companies Profiled:

• Raphas Co. Ltd.
• Becton Dickinson and Company
• NanoPass Technologies Limited
• 3M
• Zosano Pharma Corporation
• Corium International Inc.
• Valeritas Inc.
• Nitto Denko Corporation
• Microdermics Inc.
• TheraJect Inc.
• Vaxxas Pty Ltd.
• Endoderma Ltd.
• QuadMedicine
• SNvia Co. Ltd.
• Small Lab

Microneedle Drug Delivery Systems Market Industry Segmentation

By Type

• Solid
• Hollow
• Dissolving
• Coated
• Other Types

By Material

• Silicon
• Metal
• Polymer
• Other Materials

By Application

• Dermatology
• Drug Delivery
• Pain Management
• Cancer Therapy
• Vaccine Delivery
• Other Applications

By Region

• North America
• Latin America
• Europe
• APAC
• MEA

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Summary of Statistics
• 1.3. Key Market Characteristics & Attributes
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

• 3.1. Risk Assessment
  • 3.1.1. COVID-19 Crisis and Impact on Microneedle Drug Delivery Systems Market
  • 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
  • 3.1.3. Impact on Market Value (US$ Bn)
  • 3.1.4. Assessment by Key Countries
  • 3.1.5. Assessment by Key Market Segments
  • 3.1.6. Action Points and Recommendation for Suppliers
• 3.2. Key Trends Impacting the Market
• 3.3. Formulation and Product Development Trends

4. Market Background

• 4.1. Microneedle Drug Delivery Systems Market, by Key Countries
• 4.2. Microneedle Drug Delivery Systems Market Opportunity Assessment (US$ Bn)
  • 4.2.1. Total Available Market
  • 4.2.2. Serviceable Addressable Market
  • 4.2.3. Serviceable Obtainable Market
• 4.3. Market Scenario Forecast
  • 4.3.1. Demand in optimistic Scenario
  • 4.3.2. Demand in Likely Scenario
  • 4.3.3. Demand in Conservative Scenario
• 4.4. Investment Feasibility Analysis
  • 4.4.1. Investment in Established Markets
    • 4.4.1.1. In Short Term
    • 4.4.1.2. In Long Term
  • 4.4.2. Investment in Emerging Markets
    • 4.4.2.1. In Short Term
    • 4.4.2.2. In Long Term
• 4.5. Forecast Factors - Relevance & Impact
  • 4.5.1. Top Companies Historical Growth
  • 4.5.2. Growth in Automation, By Country
  • 4.5.3. Microneedle Drug Delivery Systems Markets Adoption Rate, By Country
• 4.6. Market Dynamics
  • 4.6.1. Market Driving Factors and Impact Assessment
  • 4.6.2. Prominent Market Challenges and Impact Assessment
  • 4.6.3. Microneedle Drug Delivery Systems Markets Market Opportunities
  • 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

• 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
• 5.2. Banking on with Segments High Incremental Opportunity
• 5.3. Peer Benchmarking

6. Global Microneedle Drug Delivery Systems Market Demand Analysis 2019-2023 and Forecast, 2024-2033

• 6.1. Historical Market Analysis, 2019-2023
• 6.2. Current and Future Market Projections, 2024-2033
• 6.3. Y-o-Y Growth Trend Analysis

7. Global Microneedle Drug Delivery Systems Market Value Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Type

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Bn) Analysis By Type, 2019-2023
• 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Type, 2024-2033
  • 8.3.1. Solid
  • 8.3.2. Hollow
  • 8.3.3. Dissolving
  • 8.3.4. Coated
  • 8.3.5. Other Types
• 8.4. Market Attractiveness Analysis By Microneedle Drug Delivery Systems

9. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Material

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Bn) Analysis By Material, 2019-2023
• 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Material, 2024-2033
  • 9.3.1. Silicon
  • 9.3.2. Metal
  • 9.3.3. Polymer
  • 9.3.4. Other Materiales
• 9.4. Market Attractiveness Analysis By Application

10. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Application

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
  • 10.3.1. Dermatology
  • 10.3.2. Drug Delivery
  • 10.3.3. Pain Management
  • 10.3.4. Cancer Therapy
  • 10.3.5. Vaccine Delivery
  • 10.3.6. Other Applications
• 10.4. Market Attractiveness Analysis By Application

11. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
• 11.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2024-2033
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. Asia Pacific
  • 11.3.5. Middle East and Africa (MEA)
• 11.4. Market Attractiveness Analysis By Region

12. North America Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 12.1. Introduction
• 12.2. Pricing Analysis
• 12.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
  • 12.4.1. By Country
    • 12.4.1.1. U.S.
    • 12.4.1.2. Canada
  • 12.4.2. By Type
  • 12.4.3. By Application
  • 12.4.4. By Application
• 12.5. Market Attractiveness Analysis
  • 12.5.1. By Country
  • 12.5.2. By Material
  • 12.5.3. By Application
  • 12.5.4. By Application

13. Latin America Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Pricing Analysis
• 13.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
  • 13.4.1. By Country
    • 13.4.1.1. Brazil
    • 13.4.1.2. Mexico
    • 13.4.1.3. Rest of Latin America
  • 13.4.2. By Type
  • 13.4.3. By Application
  • 13.4.4. By Application
• 13.5. Market Attractiveness Analysis
  • 13.5.1. By Country
  • 13.5.2. By Material
  • 13.5.3. By Application
  • 13.5.4. By Application

14. Europe Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Pricing Analysis
• 14.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
  • 14.4.1. By Country
    • 14.4.1.1. Germany
    • 14.4.1.2. France
    • 14.4.1.3. U.K.
    • 14.4.1.4. Italy
    • 14.4.1.5. Spain
    • 14.4.1.6. Russia
    • 14.4.1.7. Rest of Europe
  • 14.4.2. By Type
  • 14.4.3. By Application
  • 14.4.4. By Application
• 14.5. Market Attractiveness Analysis
  • 14.5.1. By Country
  • 14.5.2. By Material
  • 14.5.3. By Application
  • 14.5.4. By Application

15. Asia Pacific Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Pricing Analysis
• 15.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
  • 15.4.1. By Country
    • 15.4.1.1. China
    • 15.4.1.2. Japan
    • 15.4.1.3. South Korea
    • 15.4.1.4. India
    • 15.4.1.5. Australia
    • 15.4.1.6. Rest of Asia Pacific
  • 15.4.2. By Type
  • 15.4.3. By Application
  • 15.4.4. By Application
• 15.5. Market Attractiveness Analysis
  • 15.5.1. By Country
  • 15.5.2. By Material
  • 15.5.3. By Application
  • 15.5.4. By Application

16. Middle East and Africa Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Pricing Analysis
• 16.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
  • 16.4.1. By Country
    • 16.4.1.1. Saudi Arabia
    • 16.4.1.2. South Africa
    • 16.4.1.3. Israel
    • 16.4.1.4. UAE
    • 16.4.1.5. Rest of Middle East and Africa
  • 16.4.2. By Type
  • 16.4.3. By Application
  • 16.4.4. By Application
• 16.5. Market Attractiveness Analysis
  • 16.5.1. By Country
  • 16.5.2. By Material
  • 16.5.3. By Application
  • 16.5.4. By Application

17. Key Countries Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
  • 17.1.1. Market Value Proportion Analysis, By Key Countries
  • 17.1.2. Global Vs. Country Growth Comparison
• 17.2. US Microneedle Drug Delivery Systems Market Analysis
  • 17.2.1. Value Proportion Analysis by Market Taxonomy
  • 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.2.2.1. By Type
    • 17.2.2.2. By Application
    • 17.2.2.3. By Application
• 17.3. Canada Microneedle Drug Delivery Systems Market Analysis
  • 17.3.1. Value Proportion Analysis by Market Taxonomy
  • 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.3.2.1. By Material
    • 17.3.2.2. By Application
    • 17.3.2.3. By Application
• 17.4. Mexico Microneedle Drug Delivery Systems Market Analysis
  • 17.4.1. Value Proportion Analysis by Market Taxonomy
  • 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.4.2.1. By Type
    • 17.4.2.2. By Application
    • 17.4.2.3. By Application
• 17.5. Brazil Microneedle Drug Delivery Systems Market Analysis
  • 17.5.1. Value Proportion Analysis by Market Taxonomy
  • 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.5.2.1. By Material
    • 17.5.2.2. By Application
    • 17.5.2.3. By Application
• 17.6. Germany Microneedle Drug Delivery Systems Market Analysis
  • 17.6.1. Value Proportion Analysis by Market Taxonomy
  • 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.6.2.1. By Type
    • 17.6.2.2. By Application
    • 17.6.2.3. By Application
• 17.7. France Microneedle Drug Delivery Systems Market Analysis
  • 17.7.1. Value Proportion Analysis by Market Taxonomy
  • 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.7.2.1. By Type
    • 17.7.2.2. By Application
    • 17.7.2.3. By Application
• 17.8. Italy Microneedle Drug Delivery Systems Market Analysis
  • 17.8.1. Value Proportion Analysis by Market Taxonomy
  • 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.8.2.1. By Type
    • 17.8.2.2. By Application
    • 17.8.2.3. By Application
• 17.9. India Microneedle Drug Delivery Systems Market Analysis
  • 17.9.1. Value Proportion Analysis by Market Taxonomy
  • 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.9.2.1. By Type
    • 17.9.2.2. By Application
    • 17.9.2.3. By Application
• 17.10. UK Microneedle Drug Delivery Systems Market Analysis
  • 17.10.1. Value Proportion Analysis by Market Taxonomy
  • 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.10.2.1. By Material
    • 17.10.2.2. By Application
    • 17.10.2.3. By Application
• 17.11. Australia Microneedle Drug Delivery Systems Market Analysis
  • 17.11.1. Value Proportion Analysis by Market Taxonomy
  • 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.11.2.1. By Type
    • 17.11.2.2. By Application
    • 17.11.2.3. By Application
• 17.12. China Microneedle Drug Delivery Systems Market Analysis
  • 17.12.1. Value Proportion Analysis by Market Taxonomy
  • 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.12.2.1. By Type
    • 17.12.2.2. By Application
    • 17.12.2.3. By Application
• 17.13. Japan Microneedle Drug Delivery Systems Market Analysis
  • 17.13.1. Value Proportion Analysis by Market Taxonomy
  • 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.13.2.1. By Type
    • 17.13.2.2. By Application
    • 17.13.2.3. By Application
• 17.14. South Korea Microneedle Drug Delivery Systems Market Analysis
  • 17.14.1. Value Proportion Analysis by Market Taxonomy
  • 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.14.2.1. By Type
    • 17.14.2.2. By Application
    • 17.14.2.3. By Application
• 17.15. Israel Microneedle Drug Delivery Systems Market Analysis
  • 17.15.1. Value Proportion Analysis by Market Taxonomy
  • 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.15.2.1. By Type
    • 17.15.2.2. By Application
    • 17.15.2.3. By Application
• 17.16. South Africa Microneedle Drug Delivery Systems Market Analysis
  • 17.16.1. Value Proportion Analysis by Market Taxonomy
  • 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.16.2.1. By Type
    • 17.16.2.2. By Application
    • 17.16.2.3. By Application
• 17.17. UAE Microneedle Drug Delivery Systems Market Analysis
  • 17.17.1. Value Proportion Analysis by Market Taxonomy
  • 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.17.2.1. By Type
    • 17.17.2.2. By Application
    • 17.17.2.3. By Application
• 17.18. Spain Microneedle Drug Delivery Systems Market Analysis
  • 17.18.1. Value Proportion Analysis by Market Taxonomy
  • 17.18.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.18.2.1. By Type
    • 17.18.2.2. By Application
    • 17.18.2.3. By Application
• 17.19. Russia Microneedle Drug Delivery Systems Market Analysis
  • 17.19.1. Value Proportion Analysis by Market Taxonomy
  • 17.19.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.19.2.1. By Type
    • 17.19.2.2. By Application
    • 17.19.2.3. By Application
• 17.20. Saudi Arabia Microneedle Drug Delivery Systems Market Analysis
  • 17.20.1. Value Proportion Analysis by Market Taxonomy
  • 17.20.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
    • 17.20.2.1. By Type
    • 17.20.2.2. By Application
    • 17.20.2.3. By Application
• 17.21. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

• 18.1. Market Analysis by Tier of Companies
• 18.2. Market Concentration
• 18.3. Market Share Analysis of Top Players
• 18.4. Market Presence Analysis
  • 18.4.1. By Regional footprint of Players
  • 18.4.2. Product footprint by Players

19. Competition Analysis

• 19.1. Competition Dashboard
• 19.2. Competition Benchmarking
• 19.3. Competition Deep Dive
  • 19.3.1. Raphas Co. Ltd.
    • 19.3.1.1. Overview
    • 19.3.1.2. Product Portfolio
    • 19.3.1.3. Sales Footprint
    • 19.3.1.4. Strategy Overview
  • 19.3.2. Becton Dickinson and Company
    • 19.3.2.1. Overview
    • 19.3.2.2. Product Portfolio
    • 19.3.2.3. Sales Footprint
    • 19.3.2.4. Strategy Overview
  • 19.3.3. NanoPass Technologies Limited
    • 19.3.3.1. Overview
    • 19.3.3.2. Product Portfolio
    • 19.3.3.3. Sales Footprint
    • 19.3.3.4. Strategy Overview
  • 19.3.4. 3M
    • 19.3.4.1. Overview
    • 19.3.4.2. Product Portfolio
    • 19.3.4.3. Sales Footprint
    • 19.3.4.4. Strategy Overview
  • 19.3.5. Zosano Pharma Corporation
    • 19.3.5.1. Overview
    • 19.3.5.2. Product Portfolio
    • 19.3.5.3. Sales Footprint
    • 19.3.5.4. Strategy Overview
  • 19.3.6. Corium International Inc.
    • 19.3.6.1. Overview
    • 19.3.6.2. Product Portfolio
    • 19.3.6.3. Sales Footprint
    • 19.3.6.4. Strategy Overview
  • 19.3.7. Valeritas Inc.
    • 19.3.7.1. Overview
    • 19.3.7.2. Product Portfolio
    • 19.3.7.3. Sales Footprint
    • 19.3.7.4. Strategy Overview
  • 19.3.8. Nitto Denko Corporation
    • 19.3.8.1. Overview
    • 19.3.8.2. Product Portfolio
    • 19.3.8.3. Sales Footprint
    • 19.3.8.4. Strategy Overview
  • 19.3.9. Microdermics Inc.
    • 19.3.9.1. Overview
    • 19.3.9.2. Product Portfolio
    • 19.3.9.3. Sales Footprint
    • 19.3.9.4. Strategy Overview
  • 19.3.10. TheraJect Inc.
    • 19.3.10.1. Overview
    • 19.3.10.2. Product Portfolio
    • 19.3.10.3. Sales Footprint
    • 19.3.10.4. Strategy Overview
  • 19.3.11. Vaxxas Pty Ltd.
    • 19.3.11.1. Overview
    • 19.3.11.2. Product Portfolio
    • 19.3.11.3. Sales Footprint
    • 19.3.11.4. Strategy Overview
  • 19.3.12. Endoderma Ltd.
    • 19.3.12.1. Overview
    • 19.3.12.2. Product Portfolio
    • 19.3.12.3. Sales Footprint
    • 19.3.12.4. Strategy Overview
  • 19.3.13. QuadMedicine
    • 19.3.13.1. Overview
    • 19.3.13.2. Product Portfolio
    • 19.3.13.3. Sales Footprint
    • 19.3.13.4. Strategy Overview
  • 19.3.14. SNvia Co. Ltd.
    • 19.3.14.1. Overview
    • 19.3.14.2. Product Portfolio
    • 19.3.14.3. Sales Footprint
    • 19.3.14.4. Strategy Overview
  • 19.3.15. Small Lab
    • 19.3.15.1. Overview
    • 19.3.15.2. Product Portfolio
    • 19.3.15.3. Sales Footprint
    • 19.3.15.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology